Precision BioSciences Reports First Quarter 2024 Financial Results and Provides Business Update marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.
Precision BioSciences Announces Receipt of FDA Fast Track Designation for ECUR-506, iECURE's Program for the Treatment of Neonatal Onset Ornithine Transcarbamylase (OTC) Deficiency marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.
HC Wainwright reissued their buy rating on shares of Precision BioSciences (NASDAQ:DTIL – Free Report) in a research note published on Wednesday morning, Benzinga reports. They currently have a $60.00 target price on the stock. Precision BioSciences Stock Down 9.1 % Shares of NASDAQ:DTIL opened at $9.74 on Wednesday. The stock has a market cap […]
Precision BioSciences, Inc. Expected to Earn Q1 2025 Earnings of ($0.85) Per Share (NASDAQ:DTIL) themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.